CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 Value chain analysis
3.5 Government regulations
3.6 Market share analysis, 2015
3.7 Market Dynamics

3.7.1 Drivers

3.7.1.1 Rising incidence of chronic and infectious diseases and a growing geriatric population
3.7.1.2 Technological advancements
3.7.1.3 Increasing need for accurate, precise and rapid diagnostic tests
3.7.1.4 Growing demand for next generation immunodiagnostics platform
3.7.1.5 Demand for personalized medicine

3.7.2 Restraints

3.7.2.1 High cost of immunodiagnostic products
3.7.2.2 Stringent government regulations
3.7.2.3 Reluctance in adoption of advanced technologies in emerging economies

3.7.3 Opportunities

3.7.3.1 Presence of large unmet diagnostic needs in emerging economies
3.7.3.2 Conjunction of personalized and point of care technologies

CHAPTER 4 WORLD IMMUNODIAGNOSTICS MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Reagents

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Instrument

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Services & software

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

CHAPTER 5 WORLD IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY

5.1 Overview

5.1.1 Market size and forecast

5.2 Enzyme-linked immunosorbent assay (ELISA)

5.2.1 Market size and forecast

5.3 Chemiluminescence immunoassay (CLIA)

5.3.1 Market size and forecasts

5.4 Radioimmunoassay (RIA)

5.4.1 Market size and forecast

5.5 Fluorescence immunoassay (FIA)

5.5.1 Market size and forecast

5.6 Rapid tests

5.6.1 Market size and forecast

5.7 Others

5.7.1 Market size and forecast

CHAPTER 6 WORLD IMMUNODIAGNOSTICS MARKET, BY APPLICATION

6.1 Overview

6.1.1 Market size and forecast

6.2 Infectious diseases

6.2.1 Market size and forecast

6.3 Oncology and endocrinology

6.3.1 Market size and forecast

6.4 Bone and mineral diseases

6.4.1 Market size and forecast

6.5 Autoimmunity disorders

6.5.1 Market size and forecast

6.6 Cardiac biomarkers

6.6.1 Market size and forecast

6.7 Drug monitoring

6.7.1 Market size and forecast

6.8 Other applications

6.8.1 Market size and forecast

CHAPTER 7 WORLD IMMUNODIAGNOSTICS MARKET, BY END USERS

7.1 Overview

7.1.1 Market size and forecast

7.2 Clinical laboratories

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 Hospitals

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 Academic and research centers

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 Pharmaceutical and biotechnology industry

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

7.6 Others

7.6.1 Key market trends
7.6.2 Key growth factors and opportunities
7.6.3 Market size and forecast

CHAPTER 8 IMMUNODIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022

8.1 Overview

8.1.1 Market size and forecast

8.2 North America

8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast

8.2.4.1 U.S.Market size and forecast
8.2.4.2 canada Market size and forecast
8.2.5.3 Mexico Market size and forecast

8.3 Europe

8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast

8.3.3.1 Germany Market size and forecast
8.3.3.2 France Market size and forecast
8.3.3.3 U.K.Market size and forecast
8.3.3.4 Rest of Europe Market size and forecast

8.4 Asia-Pacific

8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast

8.4.3.1 India Market size and forecast
8.4.3.2 China Market size and forecast
8.4.3.3 Japan Market size and forecast
8.4.3.4 Australia Market size and forecast

8.5 LAMEA

8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast

8.5.3.1 Latin America Market size and forecast
8.5.3.2 Middle East Market size and forecast
8.5.3.3 Africa Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1 Abbott Laboratories

9.1.1 Company Overview
9.1.2 Company Snapshot
9.1.3 Operating Business Segments
9.1.4 Business Performance
9.1.5 Key Strategic Moves & Developments

9.2 Siemens AG

9.2.1 Company Overview
9.2.2 Company Snapshot
9.2.3 Operating Business Segments
9.2.4 Financial Performance
9.2.5 Key Strategic Moves and Developments

9.3 Immunodiagnostic Systems Holdings Plc

9.3.1 Company Overview
9.3.2 Company Snapshot
9.3.3 Operating Business Segments
9.3.4 Business Performance
9.3.5 Key Strategic Moves & Developments

9.4 DiaSorin S.p.A.

9.4.1 Company Overview
9.4.2 Operating Business Segments
9.4.3 Business Performance
9.4.4 Key Strategic Moves & Developments

9.5 Johnson & Johnson Services, Inc.

9.5.1 Company Overview
9.5.2 Operating Business Segments
9.5.3 Business Performance
9.5.4 Key Strategic Moves & Developments

9.6 F. Hoffmann-La Roche Ltd

9.6.1 Company Overview
9.6.2 Operating Business Segments
9.6.3 Business Performance
9.6.4 Key Strategic Moves & Developments

9.7 Sysmex Corporation

9.7.1 Company Overview
9.7.2 Operating Business Segments
9.7.3 Business Performance
9.7.4 Key Strategic Moves & Developments

9.8 Danaher Corporation(Beckman Coulter)

9.8.1 Company Overview
9.8.2 Company Snapshot
9.8.3 Operating Business Segments
9.8.4 Business Performance
9.8.5 Key Strategic Moves and Developments

9.9 Thermo Fisher Scientific Inc.

9.9.1 Company Overview
9.9.2 Company Snapshot
9.9.3 Operating Business Segments
9.9.4 Business Performance
9.9.5 Key Strategic Moves and Developments

9.10 Bio-Rad Laboratories, Inc.

9.10.1 Company Overview
9.10.2 Company Snapshot
9.10.3 Operating Business Segments
9.10.4 Business Performance
9.10.5 Key Strategic Moves and Developments

Other players in the value chain include (profiles not included in the report)

Arkray, Inc.,
Alere, Inc.,
Merck Millipore,
Becton, Dickinson and Company,
Biomerieux SA,
Medicaroid Corporation,
Qiagen NV,
Affimetrix,
ImmunoDX,
Meridian Bioscience